Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03579173 · ClinicalTrials.gov registry record
Determinants of Early Cystic Fibrosis Lung Disease
A clinical trial, sponsored by Indiana University.
- Completed
- Registry status
- 61
- Enrollment target
NCT03579173: Completed study, sponsored by Indiana University.
NCT03579173 is a clinical trial that has completed, run by Indiana University. The registered enrollment target is 61 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03579173 has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- 61 participants
- Enrollment target
Study Summary
The overall objective of this study is to determine the impact early nutritional and respiratory indices have on early CF lung disease. This knowledge will guide clinical management of infants with CF, who are now primarily diagnosed through newborn screening.
Primary Outcome
Forced expiratory volume in 0.5 seconds
Interventions
- DIAGNOSTIC_TEST Infant PFT
- DIAGNOSTIC_TEST Lung Clearance Index
- DIAGNOSTIC_TEST Passive tidal breathing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2018-05-08 |
| Est. Completion | 2019-02-06 |
What the finished NCT03579173 record still lists
NCT03579173 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 61 participants, a relatively small participant target.
The record links to 0 conditions, and to 3 interventions - of which Infant PFT is the first listed.
NCT03579173 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03579173 about?
NCT03579173 is a clinical study titled "Determinants of Early Cystic Fibrosis Lung Disease". The overall objective of this study is to determine the impact early nutritional and respiratory indices have on early CF lung disease. This knowledge will guide clinical management of infants with CF, who are now primarily diagnosed through newborn screening.
What is the current status of trial NCT03579173?
This trial is currently completed. The enrollment target is 61 participants. The study started on 2018-05-08. Estimated completion is 2019-02-06.
What interventions are being tested in trial NCT03579173?
The interventions under investigation include: Infant PFT (DIAGNOSTIC_TEST), Lung Clearance Index (DIAGNOSTIC_TEST), Passive tidal breathing (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03579173?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04115306 · 61 participants · Phase 1
Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer
- NCT05070845 · 61 participants · Phase 2
Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia
- NCT05187832 · 61 participants · Phase 1
A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer
- NCT05269316 · 61 participants · Phase 1
Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI